- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Colon Cancer in France
Total 5211 results
-
NovartisCompletedPain | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Hypercalcemia of MalignancyUnited States
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedHead and Neck CancerUnited States
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingLung Adenocarcinoma | Lung Large Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Minimally Invasive Lung Adenocarcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Lung Squamous Cell Carcinoma | Lung Adenosquamous CarcinomaUnited States
-
Sumitomo Pharma America, Inc.CompletedColorectal CancerUnited States, Canada, Spain, Australia, China, Hong Kong, Israel, Czechia, France, Japan, Belgium, Germany, Netherlands, Italy, Korea, Republic of, Singapore
-
Eli Lilly and CompanyCompletedColorectal CancerUnited States, Germany, Italy, Spain, Romania, Taiwan, Belgium, France, Hungary, Japan, Austria, Korea, Republic of, Australia, Sweden, Netherlands, Finland, Argentina, Czechia, Brazil, Greece, India, Israel, Denmark, Portugal, Puerto Rico and more
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Hoffmann-La RocheCompletedColorectal CancerUnited States, Belgium, Canada, China, Finland, France, Greece, Hungary, Korea, Republic of, Portugal, Spain, Thailand, United Kingdom, Australia, Germany, Israel, Singapore, Italy, Switzerland, Taiwan, New Zealand, Brazil, Hong Kong, Irelan... and more
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedPancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell CarcinomaUnited States
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Belgium, Taiwan, Australia, United Kingdom
-
Point TherapeuticsTerminatedAdenocarcinoma | Neoplasm Metastasis | Pancreatic CancerUnited States
-
AmgenCompletedCancer | Giant Cell Tumor of Bone | Giant Cell Tumors | Benign Giant Cell TumorsUnited States, Canada, Sweden, Poland, Germany, Netherlands, Australia, Italy, Austria, Spain, France, United Kingdom
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineRecruitingOvarian CancerArgentina, Brazil
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Skin Reactions Secondary to Radiation TherapyUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Taiwan, Italy, Australia, Malaysia, United States, Netherlands, Turkey, France, Germany
-
National Cancer Institute (NCI)Active, not recruitingStage IV Lung Cancer AJCC v8 | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain
-
Tesaro, Inc.Gynecologic Oncology GroupTerminated
-
Spectrum Pharmaceuticals, IncCompletedBreast Cancer | NeutropeniaUnited States, Canada, Korea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedRadiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck CancerHead and Neck Cancer | AnemiaUnited States, Canada, Korea, Republic of
-
AEterna ZentarisCompletedEndometrial CancerUnited States, Spain, Canada, Ireland, Norway, Austria, Denmark, Israel, United Kingdom, Belgium, Finland, Romania, Czechia, Italy, Poland, Germany, Netherlands, Belarus, Bosnia and Herzegovina, Bulgaria, Russian Federation, Ukraine
-
Spectrum Pharmaceuticals, IncCompletedBreast Cancer | NeutropeniaUnited States, Canada, India, Hungary, Korea, Republic of, Poland
-
Iovance Biotherapeutics, Inc.RecruitingSquamous Cell Carcinoma of the Head and Neck | Metastatic Melanoma | Non-small Cell Lung CancerUnited States, Spain, Canada, France, Germany, Greece, Switzerland, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Oral ComplicationsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingHead and Neck CancerUnited States, Canada, Saudi Arabia, China
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnCervical CancerUnited States, Canada
-
Hoffmann-La RocheCompletedOvarian CancerItaly, Austria, Belgium, France, Germany, Spain, Netherlands, Sweden, Denmark, Norway
-
Daiichi Sankyo, Inc.CompletedPancreatic CancerUnited States, Canada, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | TFE3-Rearranged Renal Cell CarcinomaUnited States, Puerto Rico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedHead and Neck CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
-
National Cancer Institute (NCI)Karolinska Institutet; Vanderbilt University Medical Center, USA; New England... and other collaboratorsTerminatedGastric Cancer | Intestinal Metaplasia | Non-Atrophic GastritisSpain, Lithuania, Taiwan, Singapore, Argentina, Korea, Republic of, Sweden, Canada, United States, Peru, Puerto Rico, Mexico, Chile, Turkey, Belgium, Kenya, Malaysia, Vietnam, Colombia, Israel, Brazil, Nepal, Switzerland, Japan, Congo,... and more
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Australia, China, Ukraine, Spain, United Kingdom, Turkey, Mexico, Brazil, Belgium, Denmark, Germany, Greece, Portugal, Russian Federation, Taiwan, France, Kenya, Thailand, Romania, Italy, Czechia, Hu... and more
-
Sumitomo Pharma Switzerland GmbHActive, not recruiting